Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|June 16, 2012
Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine mattersGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapyGeoffrey Y Ku, Karyn A Goodman, Valerie W Rusch, et al.
Transplantation|September 28, 2002
Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extractJohn M Fidler, Geoffrey Y Ku, Duane Piazza, et al.
Psycho-Oncology|October 19, 2013
Depression, cytokines, and pancreatic cancerWilliam Breitbart, Barry Rosenfeld, Kristen Tobias, et al.
AJR. American Journal of Roentgenology|September 9, 2020
Role of Imaging in Esophageal Cancer Management in 2020: Update for RadiologistsVetri Sudar Jayaprakasam, Randy Yeh, Geoffrey Y Ku, et al.
The Cochrane Database of Systematic Reviews|August 23, 2017
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerBalamurugan A Vellayappan, Yu Yang Soon, Geoffrey Y Ku, et al.
Annals of Surgery|November 28, 2018
Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?Sebastian Mondaca, Sam S Yoon, Vivian E Strong, et al.
American Journal of Clinical Oncology|December 6, 2012
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancerYelena Y Janjigian, Geoffrey Y Ku, Jenny C Campbell, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 24, 2021
Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancerSmita Sihag, Geoffrey Y Ku, Kay See Tan, et al.
Cancer Investigation|February 17, 2009
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumorsGeoffrey Y Ku, Eileen M O'Reilly, Leonard B Saltz, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|June 16, 2012
Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine mattersGeoffrey Y Ku, Benjamin A Haaland, Gilberto de Lima Lopes
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapyGeoffrey Y Ku, Karyn A Goodman, Valerie W Rusch, et al.
Transplantation|September 28, 2002
Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extractJohn M Fidler, Geoffrey Y Ku, Duane Piazza, et al.
Psycho-Oncology|October 19, 2013
Depression, cytokines, and pancreatic cancerWilliam Breitbart, Barry Rosenfeld, Kristen Tobias, et al.
AJR. American Journal of Roentgenology|September 9, 2020
Role of Imaging in Esophageal Cancer Management in 2020: Update for RadiologistsVetri Sudar Jayaprakasam, Randy Yeh, Geoffrey Y Ku, et al.
The Cochrane Database of Systematic Reviews|August 23, 2017
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerBalamurugan A Vellayappan, Yu Yang Soon, Geoffrey Y Ku, et al.
Annals of Surgery|November 28, 2018
Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?Sebastian Mondaca, Sam S Yoon, Vivian E Strong, et al.
American Journal of Clinical Oncology|December 6, 2012
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancerYelena Y Janjigian, Geoffrey Y Ku, Jenny C Campbell, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 24, 2021
Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancerSmita Sihag, Geoffrey Y Ku, Kay See Tan, et al.
Cancer Investigation|February 17, 2009
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumorsGeoffrey Y Ku, Eileen M O'Reilly, Leonard B Saltz, et al.
Pageof 11